My Treatment Approach: Optimizing Care for Relapsed / Refractory Multiple Myeloma: Translating Evidence to Clinical Practice - Episode 3
Real Life Clinical Practice Use of Selinexor: Dosing Strategies, Supportive Care, and Strategies to Incorporate into Novel Selinexor-Based Regimens
The key opinion leaders examine selinexor combinations and dosing strategies they currently employ, while also addressing how the frequency of treatment-related adverse events (TRAEs) associated with selinexor varies with lower dosing regimens in the context of managing early relapse multiple myeloma.
Video content above is prompted by the following:
- What selinexor combinations & doses are you currently using in your clinical practice?
- What has your experience been with selinexor based-regimens? How have the frequency of TRAEs associated with Selinexor differed with lower dosing?
- What has your experience been with selinexor based-regimens? How have the frequency of TRAEs associated with Selinexor differed with lower dosing?
- Please comment on any differences or similarities between your Selinexor prescribing patterns & experiences.
Related Content:
